Hormone replacement therapy cuts postmenopausal fracture risk

Washington, Sept 20 : A new study has shown that hormone replacement therapy can significantly reduce the risk of fractures in postmenopausal women.

The data analysed from the end of the 1970s to the late 1990s showed that the risk of fractures with the use of hormone replacement therapy.

The hip fracture rate dropped by 39 percent, while the distal forearm fracture rate fell by 33 percent among women aged 50-64 years.

It is shown that treatment with oestrogen reduces the risk of osteoporosis and fracture.

Professor Haakon Meyer, at the Norwegian Institute of Public Health and University of Oslo said that based on data from the Oslo Health Studies, we have estimated that almost half of the decline in fracture rates among women in the early phase after menopause in Oslo can be caused by hormone replacement therapy.

However, in recent years, the use of post-menopausal hormone replacement therapy has been significantly reduced.

This is the result of new studies that have shown that such treatment leads to increased risk of breast cancer and may increase the risk of cardiovascular disease.

Meyer said that future monitoring of fracture frequency in the population is therefore important to examine whether this has resulted in a new increase in fracture frequency.

ANI